The content on this site is intended for healthcare professionals only
Jan Geissler speaks with ecancer at EHA 23 about the incorporation of patient reported outcomes (PROs) alongside clinical outcomes in haematology.
He discusses the essential consideration of patients priorities in treating and living with cancer, and the representation of patient advocacy groups at the conference.
Jan describes the enthusiasm for engaging patients in their treatment and wellbeing, and for incorporating PRO tools to improve clinicians abilities to offer the best care to an individual, and notes the many steps still ahead refining care.
Patient reported outcomes and quality of life were also discussed at ASCO 2018 by Dr Fabrice Denis.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
Social determinants and survival outcomes in early-onset colorectal cancer in the US
The added value of integrative medicine
New classification for identifying HR myeloma based on cytogenetic abnormalities
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
GIST tumours and soft tissue sarcomas
Best practice in HRRm testing in patients with metastatic prostate cancer
